Next Science Limited Stock Today
Next Science is trading at 0.001 as of the 3rd of March 2026. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.001. The performance scores are derived for the period starting the 3rd of December 2025 and ending today, the 3rd of March 2026. Click here to learn more.
Valuation
Check how we calculate scores
Next Pink Sheet Highlights
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Next Science Limited [NXSCF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Small-Cap' category with a current market capitalization of 112.89 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Next Science's market, we take the total number of its shares issued and multiply it by Next Science's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Next Science Limited classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 214.79 M outstanding shares.
Next Science Limited has accumulated about 11.06 M in cash with (8.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Next Science Probability Of Bankruptcy
Next Science Limited Risk Profiles
| Mean Deviation | 16.63 | |||
| Semi Deviation | 17.78 | |||
| Standard Deviation | 53.91 | |||
| Variance | 2905.97 |
Next Stock Against Markets
Next Pink Sheet Analysis Notes
About 53.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.05. Next Science Limited had not issued any dividends in recent years. Next Science Limited, a medical technology company, researches, develops, and commercializes technologies that address the impacts of biofilms in human health in the United States and Australia. Next Science Limited was founded in 2012 and is headquartered in Chatswood, Australia. Next Science operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.The quote for Next Science Limited is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Next Science Limited contact Judith MBA at 61 2 8607 5126 or learn more at https://www.nextscience.com.Next Science Limited Investment Alerts
| Next Science Limited is not yet fully synchronised with the market data | |
| Next Science Limited is way too risky over 90 days horizon | |
| Next Science Limited has some characteristics of a very speculative penny stock | |
| Next Science Limited appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 8.95 M. Net Loss for the year was (9.35 M) with profit before overhead, payroll, taxes, and interest of 6.94 M. | |
| Next Science Limited has accumulated about 11.06 M in cash with (8.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 53.0% of the company outstanding shares are owned by corporate insiders |
Next Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 112.89 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Next Science's market, we take the total number of its shares issued and multiply it by Next Science's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Next Profitablity
The company has Profit Margin (PM) of (1.12) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.14) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.14.Next Science Predictive Daily Indicators
Next Science intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Next Science pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Next Science Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Next Science pink sheet to make a market-neutral strategy. Peer analysis of Next Science could also be used in its relative valuation, which is a method of valuing Next Science by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Next Science Corporate Management
| Judith MBA | CEO MD | Profile | |
| Michael Morello | VP Sales | Profile | |
| Jacqueline CA | Chief Officer | Profile | |
| Matthew Myntti | Founder CTO | Profile | |
| Jon Swanson | Chief Officer | Profile | |
| AGIA BA | Company Sec | Profile |
Other Information on Investing in Next Pink Sheet
Next Science financial ratios help investors to determine whether Next Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Next with respect to the benefits of owning Next Science security.